JUMP REPORT
| Avg Daily Volume: 1,291,993 Market Cap: 10.95B Sector: Healthcare Short Interest: 1.42 |
EARNINGS EXPECTATIONS:
THIS QTR: EPS: .75/share REV: 1, 090/M
___________________________________________________________
LAST QTR: EPS: .50/share ACTUAL: .57/share (BEAT)
____________________________________________________________
NEXT QTR: EPS: .56/share REV: 975.9/M
______________________________________________________
FULL YR: EPS: 2.46/share REV: 4,000/M
______________________________________________________
*These are the base metrics we will be watching against the actual release numbers
______________________________________________________
BEAT/MISS RECORD: 53% OF THE TIME THEY BEAT ESTIMATES
PRIOR ‘JUMP ZONE’ MOVES (LAST 3 QTRS %) 8.2, -7.74, 8.5
EXPECTED JUMP MOVE: 10%
Links To Latest News and Headlines
NASDAQ has given Dentsply Sirona Inc. notice that its failure to file its latest quarterly report with the Securities and Exchange Commission violates NASDAQ listing rules and could result in delisting.
Moderna (NASDAQ: MRNA) is having a terrific year, raking in profits and generating plenty of cash due to its COVID-19 vaccine. As its business grows and the company plans for a post-COVID future, it needs to make smart decisions with its money. On May 9, Jorge Gomez was set to become Moderna’s CFO, replacing David Meline, who is planning to retire.
Dentsply Sirona Inc. said Wednesday it has received a written notification from the Nasdaq exchange warning that it is no longer in compliance with listing rules because it has not yet filed its quarterly 10-Q report with the Securities and Exchange Commission. The maker of dental products and technology said last week the 10-Q was delayed by an internal probe of financial reporting involving former and current executives. The announcement led to the ouster of Moderna Inc.’s CFO Jorge Gomez afte
CHARLOTTE, N.C., May 18, 2022 (GLOBE NEWSWIRE) — DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) received written notification from The NASDAQ Stock Market (“Nasdaq”) on May 12, 2022 that the Company is no longer in compliance with the Nasdaq Listing Rules since the Company has not yet filed its Quarterly Report on Form 10-Q for the period ended March 31, 2022 (the “Quarterly Report”). Nasdaq Listing Rule 5250(c)(1) requires Nasdaq-listed companies to timely file all pe
Moderna Inc’s (NASDAQ: MRNA) chairman comes forward with a determined defense of the board’s executive hiring process after being forced to fire its new chief financial officer just a day after taking charge. Afeyan said the executive search company contracted by Moderna was also blameless because it was unaware of the probe by Dentsply Sirona Inc (NASDAQ: XRAY). “I’m quite convinced that those facts were not obtainable to us had a legal context,” Afeyan said in an interview with the Financial T
StockJumpers analysis and trade plans are uploaded generally 1 HOUR BEFORE MARKETS CLOSE (3PM EST) for most events.
“I’m sorry, this content is for members only. To access this content, you must log in with your membership credentials – OR if you are not a member yet, visit our registration page here and get signed up Looking forward to having you on-board ASAP”
There is a significant amount of data behind the scenes involved in the analysis and trade plan tab above, that does not get put into the report. Too much information for traders often confuses things – so this is striped down to only what it needed to make the best possible decision(s) on trading the trajectory.
NOTICE: All data on this site has been published for informational and educational purposes only and does not constitute an offer to sell nor a solicitation of an offer to buy any security which may be referenced here or in our websites. StockJumpers is not an Investment Adviser and relies on the publisher’s exemption as defined in Section 401(f) of the Uniform Securities Act, and provides no personal advice or recommendations. The services and published information contained herein is for non-commercial, educational use and display. StockJumpers and any of its affiliates does not represent that the securities or services discussed are suitable for any investor. You should assume that StockJumpers and or its management has or will take a position in the stock, whether it is stated or not. You are further advised not to rely on any information contained in this report and associated websites in the process of making a fully informed investment decision. Trading is risky and you can lose your investment. For the complete risk disclosure and other legal information please review the full Terms of Use Agreement.